Close
FINDING CURES TOGETHER<sup>SM</sup>

American Association for Cancer Research Welcomes New Board of Directors, Nominating Committee Members

3/20/2017

​PHILADELPHIA — The members of the American Association for Cancer Research (AACR) have elected five members to serve on the AACR Board of Directors for the 2017-2020 term and four members to serve on the Nominating Committee for the 2017-2019 term. These top scientists in the world of cancer research will begin their terms at the AACR Annual Meeting 2017, to be held in Washington, D.C., April 1-5.

The following five scientists were elected to the Board of Directors:

Cory Abate-Shen, PhD, Michael and Stella Chernow chair of urological oncology, Department of Urology; professor, Departments of Pathology and Cell Biology, Systems Biology, Medicine, and the Institute of Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York; leader, Prostate Program; and associate director, translational research, Herbert Irving Comprehensive Cancer Center of Columbia University

Philip D. Greenberg, MD, co-editor-in-chief, Cancer Immunology Research (2015-present); member and head, Program in Immunology, Fred Hutchinson Cancer Research Center; and professor, medicine and immunology, University of Washington School of Medicine, Seattle

Gordon B. Mills, MD, PhD, department chair, Department of Systems Biology 1, Division of Basic Science Research; professor, medicine, immunology, and breast medical oncology; Ann Rife chair in gynecology; administrative director, Kleberg Center for Molecular Markers; co-director, Zayed Institute for Personalized Cancer Therapy, Department of Systems Biology 1; administrative director, Division of Cancer Medicine; chief, Section of Molecular Therapeutics; Olga Keith Weiss Distinguished University chair for cancer research; co-head, Women’s Cancer Moonshot; and member, Tumor Biology Program, The University of Texas MD Anderson Cancer Center, Houston

Martine J. Piccart, MD, PhD, FAACR, Fellow of the AACR Academy; president, Teaching College of the Complementary Master in Medical Oncology; president, Teaching College of Oncology, Université Libre de Bruxelles, Brussels; and head, Medicine Department, Jules Bordet Institute, Brussels, Belgium

Lillian L. Siu, MD, professor, Faculty of Medicine, University of Toronto, Canada; senior medical oncologist, Princess Margaret Cancer Centre; BMO chair in precision genomics; director of Phase I Program; Cancer Genomics Program; clinical lead of Tumor Immunotherapy Program; and co-director of Robert and Maggie Bras and Family Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto

The following four scientists were elected to the Nominating Committee:

José Baselga, MD, PhD, FAACR, AACR President (2015-2016); Fellow of the AACR Academy; member, Board of Directors (2009-2012); founding editor-in-chief, Cancer Discovery (2011-present); physician-in-chief, chief medical officer, and member, Memorial Sloan Kettering Cancer Center, New York; professor, Department of Medicine, Weill Cornell Medical College, New York; and attending physician, Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, New York

Olivera (Olja) J. Finn, PhD, distinguished professor and director, Immunology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Karen H. Vousden, PhD, FAACR, Fellow of the AACR Academy; member, Board of Directors (2012-2015); chief scientist, Cancer Research UK, Glasgow, Scotland; senior group leader, Francis Crick Institute, London

Owen N. Witte, MD, FAACR, Fellow of the AACR Academy; member, Board of Directors (2010-2013); university professor, University of California, Los Angeles; director, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; David Saxon presidential chair in developmental immunology; distinguished professor of microbiology, immunology, and molecular genetics; distinguished professor of molecular and medical pharmacology, University of California, Los Angeles

Follow the AACR Annual Meeting 2017 on Twitter: #AACR17